Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effectMin Gao, Lawrence G. Hamann, Richard E. Nettles et al.|Nature|2010Cited by 940
Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus InfectionPaul M. Scola, Fiona McPhee, Jie Chen et al.|Journal of Medicinal Chemistry|2014Cited by 69
CCDC 984481: Experimental Crystal Structure DeterminationPaul M. Scola, Fiona McPhee, Alan Xiangdong Wang et al.|The Cambridge Structural Database|2014Cited by 0